Vivos Therapeutics (VVOS) Times Interest Earned (2020 - 2022)

Vivos Therapeutics (VVOS) has reported Times Interest Earned for 3 consecutive years, with 150.19 the latest figure, recorded in Q3 2022.

• On a quarterly basis, Times Interest Earned rose 75.44% year-over-year to 150.19 in Q3 2022; TTM through Sep 2022 was 229.75, a 66.27% increase from a year earlier, with the FY2021 full-year figure at 1455.86, down 1060.82% from the prior year.
• Times Interest Earned was 150.19 for Q3 2022 at Vivos Therapeutics, up from 188.22 in the prior quarter.
• Over five years, Times Interest Earned peaked at 58.5 in Q1 2020 and troughed at 4061.0 in Q2 2021.
• A 3-year average of 1004.64 and a median of 188.22 in 2022 frame the typical range for Times Interest Earned.
• Across the five-year window, Times Interest Earned tumbled 5722.38% in 2021 and soared 95.37% in 2022, its largest moves.
• Over 3 years, Times Interest Earned stood at 362.86 in 2020, then tumbled by 410.6% to 1852.75 in 2021, then jumped by 91.89% to 150.19 in 2022.
• The last three Times Interest Earned figures came in at 150.19 (Q3 2022), 188.22 (Q2 2022), and 174.71 (Q1 2022), per Business Quant data.